S.Res. 493Senate112th Congress (2011-2013)In Committee

A resolution recognizing that the occurrence of prostate cancer in African-American men has reached epidemic proportions and urging Federal agencies to address that health crisis by supporting education, awareness outreach, and research specifically focused on how prostate cancer affects African-American men.

Introduced June 14, 2012

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4206)

June 14, 2012

View full timeline
SenateIntro Referral

Introduced in Senate

June 14, 2012

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S4206-4207)

June 14, 2012

SenateIntro Referral

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4206)

June 14, 2012

Floor Debate

1 member

What members said about S.Res. 493 on the floor

1 Democrat
John F. Kerry
Sen. John F. KerryD-MA · Jun 14, 2012

Mr. President, as we approach Father's Day, I would like to take the opportunity to discuss an important men's health issue that has personally affected my family and the families of many of my…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued June 14, 2012

III

112th CONGRESS

2d Session

S. RES. 493

IN THE SENATE OF THE UNITED STATES

June 14, 2012

Mr. Kerry (for himself, Mr. Chambliss, Mr. Cardin, Mr. Akaka, and Mr. Wyden) submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and Pensions

RESOLUTION

Recognizing that the occurrence of prostate cancer in African-American men has reached epidemic proportions and urging Federal agencies to address that health crisis by supporting education, awareness outreach, and research specifically focused on how prostate cancer affects African-American men.

Whereas the incidence of prostate cancer in African-American men is more than one and a half times higher than in any other racial or ethnic group in the United States;

Whereas African-American men have the highest mortality rate of any ethnic and racial group in the United States, dying at a rate that is approximately two and a half times higher than other ethnic and racial groups;

Whereas that rate of mortality represents the largest disparity of mortality rates in any of the major cancers;

Whereas prostate cancer can be cured with early detection and the proper treatment, regardless of the ethnic or racial group of the cancer patient;

Whereas African Americans are more likely to be diagnosed at an earlier age and at a later stage of cancer progression than all other ethnic and racial groups, leading to lower cure rates and lower chances of survival;

Whereas, for cases diagnosed early, studies show a 5-year survival rate of nearly 100 percent, but the survival rate drops significantly to 28 percent for cases diagnosed in late stages; and

Whereas recent genomics research has increased the ability to identify men at high risk for aggressive prostate cancer: Now, therefore, be it

That the Senate—

(1)

recognizes that prostate cancer has created a health crisis for African-American men;

(2)

recognizes the importance of health coverage and access to care, as well as promoting informed decisionmaking between men and their doctors, taking into consideration the known risks and potential benefits of screening and treatment options for prostate cancer;

(3)

urges Federal agencies to support—

(A)

research to address and attempt to end the health crisis created by prostate cancer;

(B)

efforts relating to education, awareness, and early detection at the grassroots level to end that health crisis; and

(C)

the Office of Minority Health of the Department of Health and Human Services in focusing on improving health and healthcare outcomes for African Americans at an elevated risk of prostate cancer; and

(4)

urges investment by the National Cancer Institute and National Institute of Biomedical Imaging and Bioengineering, and other elements of the National Institutes of Health, as well as the Department of Defense, in research focusing on the improvement of early detection and treatment of prostate cancer, such as by using biomarkers to accurately distinguish indolent forms of prostate cancer from lethal forms and advanced imaging tools to assure the best level of individualized patient care.